Skip to main content

Nasdaq IPOs

Autoimmune biotech Landos Biopharma sets terms for $100 million IPO

5 years 8 months ago
Landos Biopharma, a Phase 2 biotech developing oral small molecule therapies for autoimmune diseases, announced terms for its IPO on Thursday. The Blacksburg, VA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpo
Renaissance Capital

Brazilian asset manager Vinci Partners prices US IPO at $18 high end

5 years 8 months ago
Vinci Partners Investments, a leading independent alternative asset manager in Brazil, raised $250 million by offering 13.9 million shares at $18, the high end of the range of $16 to $18. Vinci Partners' business segments, or strategies, include private equity, public equities,
Renaissance Capital

Life sciences SPAC Ignyte Acquisition prices $50 million IPO

5 years 8 months ago
Ignyte Acquisition, a blank check company targeting the life sciences, biotechnology and healthcare sectors, raised $50 million by offering 5 million units at $10.Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. The company is led
Renaissance Capital

Leisure SPAC ITHAX Acquisition prices upsized $210 million IPO

5 years 8 months ago
ITHAX Acquisition, a blank check company formed by Ithaca Capital Partners and AXIA Ventures Group targeting the leisure industry, raised $210 million by offering 21 million units at $10. The company offered 3.5 million more units than anticipated. Each unit consists of one
Renaissance Capital

SPAC TLG Acquisition One prices upsized $350 million IPO

5 years 8 months ago
TLG Acquisition One, a blank check company formed by The Lawrie Group, raised $350 million by offering 35 million units at $10. The company offered 5 million more units than anticipated. Each unit consists of one share of common stock and one-third of a warrant, exercisable
Renaissance Capital

Ortho Clinical Diagnostics prices IPO below the range IPO at $17

5 years 8 months ago
Ortho Clinical Diagnostics, a Carlyle-backed global provider of in vitro diagnostic products, raised $1.3 billion by offering 76 million shares at $17, below the range of $20 to $23. The company increased its offering by 6.0 million shares (9%). At pricing, Ortho Clinical raised
Renaissance Capital

Cannabis SPAC Tuatara Capital Acquisition files for a $150 million IPO

5 years 8 months ago
Tuatara Capital Acquisition, a blank check company formed by Tuatara Capital targeting the cannabis industry, filed on Wednesday with the SEC to raise up to $150 million in an initial public offering. The New York, NY-based company plans to raise $150 million by offering 15 mill
Renaissance Capital

Tech-focused SPAC Rosecliff Acquisition I files for a $200 million IPO

5 years 8 months ago
Rosecliff Acquisition I, a blank check company backed by Rosecliff Venture Management targeting technology, filed on Wednesday with the SEC to raise up to $200 million in an initial public offering. The New York, NY-based company plans to raise $200 million by offering 20 millio
Renaissance Capital

Online mortgage lender loanDepot sets terms for $300 million IPO

5 years 8 months ago
loanDepot, a nonbank lender focused on mortgages and unsecured personal loans, announced terms for its IPO on Wednesday. The Foothill Ranch, CA-based company plans to raise $300 million by offering 15 million shares (37% secondary) at a price range of $19 to $21. The IPO fl
Renaissance Capital

Chinese micro-cap EZGO jumps 353% on Tuesday's Nasdaq debut

5 years 8 months ago
In the latest sign of frenzied trading in the IPO market, a new micro-cap issuer popped more than 350% on Tuesday. EZGO Technologies (EZGO) raised $11 million by offering 2.8 million shares at a price of $4.00 in its Nasdaq listing, at a market cap of $42 million. The stock fini
Renaissance Capital
Checked
8 minutes 17 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed